Insider trading

Period: 120 months Stock: CCCC + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

40 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

40 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

40 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

40 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
40 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
40 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

40 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
16 Jan 2026
REYNO LEONARD Chief Medical Officer
Sold at will
$22.20K 10,000 at 2.22
6.0%
Not planned
18 Feb 2025
Boyle Scott N Chief Business Officer
Sold on a plan
$2.11K 669 at 3.15
0.6%
Planned (10b5-1)
14 Feb 2025
Boyle Scott N Chief Business Officer
Sold on a plan
$1.54K 490 at 3.15
0.4%
Planned (10b5-1)
8 Feb 2023
Koppikar Utpal Director
Bought
$31.74K 5,667 at 5.60
opened
First buy on file
12 Apr 2022
Hirsch Andrew President & CEO
Bought
$84.00K 10,000 at 8.40
opened
First buy on file
4 Jan 2022
Crystal Adam Chief Medical Officer
Sold, plan not stated 2×
$474.97K 15,000 at 31.66
50.0%
Sold half or more
17 Dec 2021
Salter Malcolm Director
Sold, plan not stated
$22.84K 755 at 30.25
6.4%
19 Nov 2021
Salter Malcolm Director
Sold, plan not stated
$30.28K 755 at 40.11
6.1%
15 Oct 2021
Salter Malcolm Director
Sold, plan not stated
$33.93K 755 at 44.94
5.7%
1 Oct 2021
Crystal Adam Chief Medical Officer
Sold, plan not stated 3×
$681.44K 15,000 at 45.43
100%
Sold half or more
27 Sep 2021
Prokupets Elena Director · indirect
Sold, plan not stated 2×
$92.57K 1,850 at 50.04
5.5%
24 Sep 2021
Prokupets Elena Director · indirect
Sold, plan not stated 2×
$151.06K 3,015 at 50.10
8.6%
23 Sep 2021
Prokupets Elena Director · indirect
Sold, plan not stated 4×
$966.77K 19,180 at 50.41
36.7%
22 Sep 2021
Prokupets Elena Director · indirect
Sold, plan not stated 2×
$528.41K 10,548 at 50.10
21.1%
21 Sep 2021
Prokupets Elena Director · indirect
Sold, plan not stated 2×
$517.46K 10,321 at 50.14
19.3%
17 Sep 2021
Prokupets Elena Director · indirect
Sold, plan not stated 2×
$542.49K 10,840 at 50.05
18.4%
17 Sep 2021
Salter Malcolm Director
Sold, plan not stated
$37.67K 755 at 49.89
5.5%
16 Sep 2021
Prokupets Elena Director · indirect
Sold, plan not stated 3×
$1.29M 26,499 at 48.65
33.3%
15 Sep 2021
Prokupets Elena Director · indirect
Sold, plan not stated 2×
$2.65M 54,193 at 48.82
50.3%
Sold half or more
14 Sep 2021
Prokupets Elena Director · indirect
Sold, plan not stated 2×
$49.22K 984 at 50.02
1.2%
13 Sep 2021
Prokupets Elena Director · indirect
Sold, plan not stated 2×
$333.47K 6,660 at 50.07
7.3%
10 Sep 2021
Siegel Jolie Chief Legal Officer
Sold, plan not stated
$625.00K 12,500 at 50.00
100%
Sold half or more
10 Sep 2021
Prokupets Elena Director · indirect
Sold, plan not stated 2×
$127.51K 2,550 at 50.00
2.8%
20 Aug 2021
Salter Malcolm Director
Sold, plan not stated
$30.75K 755 at 40.73
5.2%
3 Aug 2021
Fisher Stewart Chief Scientific Officer
Sold, plan not stated
$767.81K 17,057 at 45.01
42.9%
3 Aug 2021
Prokupets Elena Director · indirect
Sold, plan not stated
$650.59K 14,407 at 45.16
14.0%
2 Aug 2021
Fisher Stewart Chief Scientific Officer
Sold, plan not stated
$814.76K 18,104 at 45.00
31.3%
2 Aug 2021
Prokupets Elena Director · indirect
Sold, plan not stated
$191.61K 4,257 at 45.01
4.0%
29 Jul 2021
Fisher Stewart Chief Scientific Officer
Sold, plan not stated
$2.26M 50,211 at 45.00
46.4%
29 Jul 2021
Crystal Adam Chief Medical Officer
Sold, plan not stated
$675.00K 15,000 at 45.00
100%
Sold half or more
29 Jul 2021
Siegel Jolie Chief Legal Officer
Sold, plan not stated
$562.50K 12,500 at 45.00
100%
Sold half or more
29 Jul 2021
Prokupets Elena Director · indirect
Sold, plan not stated
$510.17K 11,336 at 45.00
9.6%
16 Jul 2021
Salter Malcolm Director
Sold, plan not stated
$28.21K 755 at 37.37
5.0%
1 Jul 2021
Crystal Adam Chief Medical Officer
Sold, plan not stated 2×
$569.67K 15,000 at 37.98
100%
Sold half or more
18 Jun 2021
Salter Malcolm Director
Sold, plan not stated
$28.08K 755 at 37.19
4.8%
21 May 2021
Salter Malcolm Director
Sold, plan not stated
$28.03K 755 at 37.12
4.6%
5 Apr 2021
Crystal Adam Chief Medical Officer
Sold, plan not stated 2×
$566.54K 15,000 at 37.77
100%
Sold half or more
6 Oct 2020
MCKEE WILLIAM Chief Financial Officer
Bought
$100.00K 5,263 at 19.00
opened
First buy on file
6 Oct 2020
COHEN MARC A Director
Bought
$95.57K 5,030 at 19.00
opened
First buy on file
6 Oct 2020
Salter Malcolm Director
Bought
$24.99K 1,315 at 19.00
9.0%
First buy on file
Showing 1–40 of 40.